Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report)’s share price was down 0.3% during trading on Wednesday . The stock traded as low as $18.80 and last traded at $18.80. 800 shares were traded during mid-day trading, a decline of 11% from the average daily volume of 900 shares. The stock had previously closed at $18.86.
Ion Beam Applications Stock Performance
The firm has a 50-day moving average of $18.30 and a 200-day moving average of $17.20.
About Ion Beam Applications
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Further Reading
- Five stocks we like better than Ion Beam Applications
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
